Allogene Therapeutics, Inc. (ALLO)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
| Previous close | 8.21 |
| Open | 8.00 |
| Bid | 7.75 x 1300 |
| Ask | 7.92 x 800 |
| Day's range | 7.67 - 8.11 |
| 52-week range | 5.41 - 17.49 |
| Volume | |
| Avg. volume | 1,974,344 |
| Market cap | 1.122B |
| Beta (5Y monthly) | 0.70 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
4 Biotech Stocks Set to Outpace Q4 Earnings Estimates
Let us look at some biotech stocks, ALLO, EDIT, NTLA and SGEN that are poised to beat on fourth-quarter earnings.
- Zacks
Strength Seen in Liquidia Technologies, Inc. (LQDA): Can Its 9.7% Jump Turn into More Strength?
Liquidia Technologies, Inc. (LQDA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
- Zacks
Allogene Therapeutics (ALLO) Soars 15.7%: Is Further Upside Left in the Stock?
Allogene Therapeutics (ALLO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
© 2023 Yahoo. All rights reserved.
